Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California and Puerto Rico, as well as in Colombia.
The last earnings update was 88 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Chemesis International. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Chemesis International's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Chemesis International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Chemesis International's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Chemesis International's earnings growth to the Canada market average as no estimate data is available.
Unable to compare Chemesis International's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if Chemesis International is high growth as no earnings estimate data is available.
Unable to determine if Chemesis International is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Chemesis International's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Chemesis International's finances.
The net worth of a company is the difference between its assets and liabilities.
Chemesis International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Chemesis International's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
Chemesis International's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
Debt is covered by short term assets, assets are 2.1x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Edgar Montero serves as Chief Executive Officer and Director of Chemesis International Inc., since July 17, 2018. Mr. Montero has been Director at GSRX Industries Inc. (“GSRX”) since August 28, 2019. For the past five years Mr. Montero has also been the Chief Executive Officer of Natural Ventures, where he has been heavily immersed in the initiation of the medical cannabis industry in Puerto Rico.
Edgar's compensation has increased whilst company is loss making.
Edgar's remuneration is about average for companies of similar size in Canada.
Management Team Tenure
Average tenure and age of the
management team in years:
The average tenure for the Chemesis International management team is less than 2 years, this suggests a new team.
CEO & Director
President & Director
Chief Financial Officer
Chief Science Officer
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The average tenure for the Chemesis International board of directors is less than 3 years, this suggests a new board.
Board of Directors
CEO & Director
President & Director
Board of Director
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
Would Chemesis International (CNSX:CSI) Might Be Better Off With Less Debt
CNSX:CSI Historical Debt, August 27th 2019 A Look At Chemesis International's Liabilities According to the balance sheet data, Chemesis International had liabilities of CA$10.9m due within 12 months, but no longer term liabilities. … But it is Chemesis International's earnings that will influence how the balance sheet holds up in the future. … When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt.
Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California and Puerto Rico, as well as in Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company is headquartered in Vancouver, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.